Back
Vincerx Pharma, Inc. 10K Form
Sell
14
VINC
Vincerx Pharma, Inc.
Last Price:
$0.0100
Seasonality Move:
18.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VINC News And Ratings
See the #1 stock for the next 7 days that we like better than VINC
VINC Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.39 |
| Price / Book: | 0.03 |
Profitability
| EPS (TTM): | -9.05000 |
|---|---|
| Net Income (TTM): | $-22.6M |
| Gross Margin: | $-1.1M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Vincerx Pharma, Inc. Earnings Forecast
Key Vincerx Pharma, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 1 years.
Vincerx Pharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Current Symbol: | VINC |
| Website: | vincerx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VINC Technical Analysis vs Fundamental Analysis
Sell
14
Vincerx Pharma, Inc. (VINC)
is a Sell
Is Vincerx Pharma, Inc. a Buy or a Sell?
-
Vincerx Pharma, Inc. stock is rated a SellThe current Vincerx Pharma, Inc. [VINC] share price is $0.0125. The Score for VINC is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.